Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26
An analysis of mutual fund portfolios revealed 29 stocks held exclusively by single schemes, with most underperforming in CY26. However, Satin Creditcare Network, Rossell Techsys, and Amanta Healthcare bucked the trend, delivering strong returns. Brooks Laboratories and EFC (I) were among those experiencing significant declines.
Stocks in news: Groww, Dr Reddy's, Waaree Energies, Lenskart, SBI
Markets experienced a sharp risk-off session on Monday, with indices declining amid broad selling. Investors are advised to avoid aggressive index bets and await clearer directional signals. Pharma and healthcare stocks remain preferred, while dips in energy and metal sectors offer accumulation opportunities.
Which sectors saw the biggest FII inflows and outflows in April?
Foreign investors remained net sellers of Indian equities in April, though the pace of outflows eased sharply from March. FIIs turned buyers in sectors such as power, capital goods and metals, while financial services, healthcare, oil & gas and automobiles continued to witness heavy selling pressure amid global uncertainty.

Q4 Results Today: Blue Dart, Utkarsh Small Finance Bank, D-Link Among 30+ Firms To Declare Earnings
Sambhv Steel Tubes, Birla Corporation and Medi Assist Healthcare Services are among the key names that will declare their quarterly earnings on May 9.

Abakkus trims banking exposure, adds solar and power-linked capital goods stocks
Aman Chowhan, Fund Manager at Abakkus Asset Manager, which manages assets worth nearly $2.06 billion, said the sharp market rebound over the past few weeks has caught many investors by surprise, even as the fund stayed selectively bullish through the correction. The Mumbai-based AMC increased exposure to renewable energy, power-linked capital goods and select metal plays, while trimming some banking exposure. Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
Market Trading Guide: Buy Nippon Life, Bharat Dynamics on Friday for gains up to 14%
Nifty ended marginally lower despite showing a consolidation breakout and improving technical indicators. Analysts expect bullish momentum to continue with upside potential in the near term. Nippon Life India Asset Management and Bharat Dynamics were highlighted as attractive trading opportunities based on strong chart patterns.

Aditya Birla Sun Life AMC joins Category III AIF rush with ₹2,000 crore fund
This follows growing investor appetite for Category III AIFs, which are increasingly being used by asset managers and wealth firms to offer hedge fund-like public market products to high-net-worth individuals (HNIs), ultra-HNIs and family offices.
Star Health to launch affordable health insurance plans targeting tier 2, 3 markets
As healthcare expenses soar, Star Health is bracing for premium increases in the next fiscal year. In a proactive move, the insurer is rolling out a series of affordable health insurance options tailored for smaller urban areas. These plans will incorporate a curated list of hospitals to not only streamline costs but also enhance accessibility for policyholders in these communities.
52 of 112 FY26 IPOs below issue price; analysts advise selective buying
Stocks such as Anlon Healthcare, Jaro Institute, VMS TMT, Shree Ram Twistex and Glottis are down in the range of 50 to 80 per cent, as per data shared by PRIME Database.

Buy, Sell Or Hold: Kalyan Jewellers, Bajaj Auto, Eternal, Siemens Energy And Max Healthcare — Ask Profit
Experts shared buy, sell and hold recommendations on NDTV Profit's 'Ask Profit' show.
India’s newest mutual fund: Bhautik Ambani wants to bring global quant power to retail investors - The Economic Times
India’s newest mutual fund: Bhautik Ambani wants to bring global quant power to retail investorsThe Economic Times
India supplies 20% of global generic medicines; its IP rules WTO-compliant: GTRI
India is a major global supplier of affordable generic medicines. The United States continues to pressure India regarding intellectual property protection for pharmaceuticals. India maintains its intellectual property regime is compliant with international trade rules. This ongoing issue reflects long-standing differences between the two nations. India's stance aims to protect its generics industry and ensure access to affordable healthcare worldwide.